R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation model

被引:47
作者
Sánchez, C [1 ]
机构
[1] H Lundbeck & Co AS, Neuropharmacol Res, DK-2500 Copenhagen, Denmark
关键词
5-HT; (5-hydroxytryptamine; serotonin); anxiolytic; citalopram; escitalopram; R-citalopram;
D O I
10.1016/S0014-2999(03)01376-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Escitalopram mediates the serotonin reuptake inhibitory effect of citalopram. To investigate the potential interactive effects between escitalopram and R-citalopram, they were studied at standard and elevated serotonin levels in a model predictive of anxiolytic activity (inhibition of footshock-induced ultrasonic vocalisation in adult rats). At standard levels, citalopram partially inhibited (64%) and escitalopram abolished (97%) vocalisation. Co-treatment with L-5-hydroxytryptophan resulted in complete inhibition with citalopram and a substantially enhanced response to escitalopram, while R-citalopram increased the vocalisation significantly. Furthermore, R-citallopram attenuated the effect of escitalopram. These findings may be relevant to the enhanced clinical efficacy seen with escitalopram compared to citalopram. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:155 / 158
页数:4
相关论文
共 14 条
[1]   Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients [J].
Burke, WJ ;
Gergel, I ;
Bose, A .
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (04) :331-336
[2]   Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials [J].
Gorman, Jack M. ;
Korotzer, Andrew ;
Su, Guojin .
CNS SPECTRUMS, 2002, 7 (04) :40-44
[3]   THE PHARMACOLOGICAL EFFECT OF CITALOPRAM RESIDES IN THE (S)-(+)-ENANTIOMER [J].
HYTTEL, J ;
BOGESO, KP ;
PERREGAARD, J ;
SANCHEZ, C .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1992, 88 (02) :157-160
[4]   Escitalopram (S-Enantiomer of citalopram):: Clinical efficacy and onset of action predicted from a rat model [J].
Montgomery, SA ;
Loft, H ;
Sánchez, C ;
Reines, EH ;
Papp, M .
PHARMACOLOGY & TOXICOLOGY, 2001, 88 (05) :282-286
[5]   Second-generation SSRIs:: Human monoamine transporter binding profile of escitalopram and R-fluoxetine [J].
Owens, MJ ;
Knight, DL ;
Nemeroff, CB .
BIOLOGICAL PSYCHIATRY, 2001, 50 (05) :345-350
[6]   AFFINITY MODULATION OF [H-3] IMIPRAMINE, [H-3] PAROXETINE AND [H-3] CITALOPRAM BINDING TO THE 5-HT TRANSPORTER FROM BRAIN AND PLATELETS [J].
PLENGE, P ;
MELLERUP, ET ;
LAURSEN, H .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1991, 206 (03) :243-250
[7]   ANTIDEPRESSIVE DRUGS CAN CHANGE THE AFFINITY OF [H-3] IMIPRAMINE AND [H-3] PAROXETINE BINDING TO PLATELET AND NEURONAL MEMBRANES [J].
PLENGE, P ;
MELLERUP, ET .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 119 (1-2) :1-8
[8]   Somatodendritic 5-HT1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT [J].
Remy, SM ;
Schreiber, R ;
Dalmus, M ;
DeVry, J .
PSYCHOPHARMACOLOGY, 1996, 125 (01) :89-91
[9]  
SANCHEZ C, 1993, BEHAV PHARMACOL, V4, P269
[10]   Assessment of relative efficacies of 5-HT1A receptor ligands by means of in vivo animal models [J].
Sanchez, C ;
Arnt, J ;
Moltzen, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 315 (03) :245-254